Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option

NCT02094443 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C
Liver Disease

Interventions

DRUG: Alisporivir
DRUG: Ribavirin

Sponsor

Debiopharm International SA